Age, Biography and Wiki
Andreas Kjær (scientist) was born on 12 April, 1963 in Copenhagen, Denmark. Discover Andreas Kjær (scientist)'s Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 60 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
61 years old |
| Zodiac Sign |
Aries |
| Born |
12 April, 1963 |
| Birthday |
12 April |
| Birthplace |
Copenhagen, Denmark |
| Nationality |
Denmark |
We recommend you to check the complete list of Famous People born on 12 April.
He is a member of famous with the age 61 years old group.
Andreas Kjær (scientist) Height, Weight & Measurements
At 61 years old, Andreas Kjær (scientist) height not available right now. We will update Andreas Kjær (scientist)'s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Andreas Kjær (scientist) Net Worth
His net worth has been growing significantly in 2022-2023. So, how much is Andreas Kjær (scientist) worth at the age of 61 years old? Andreas Kjær (scientist)’s income source is mostly from being a successful . He is from Denmark. We have estimated
Andreas Kjær (scientist)'s net worth
, money, salary, income, and assets.
| Net Worth in 2023 |
$1 Million - $5 Million |
| Salary in 2023 |
Under Review |
| Net Worth in 2022 |
Pending |
| Salary in 2022 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Andreas Kjær (scientist) Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Kjær received numerous awards over the years. Examples include the August Krogh Prize (Organization of Danish Medical Societies, 2006), Great Prize for Scientific Achievements (Scandinavian Society of Clinical Physiology and Nuclear Medicine, 2007), Global Excellence in Health Prize (2010) and the Pasteur Prize (Danish National Advanced Technology Foundation, 2011). In 2014 he was awarded an ERC advanced grant and in 2015 he was appointed member of the Danish Academy of Technical Sciences. He served as president of the Scandinavian Society for Clinical Physiology and Nuclear Medicine (SSCPNM) 2006-12 and currently is editor-in-chief of Diagnostics (Basel) as well as on advisory boards and committees.
Professor Kjær received his MD degree from the University of Copenhagen in 1989 and the same year he received the United States ECFMG license as MD. In 1994 he obtained the PhD degree, in 1996 the DMSc degree and in 2000 he was board certified as specialist in Nuclear Medicine. He was appointed full professor and chief physician in 2003. He has been a visiting scientist at Salk Institute (La Jolla) and Emory University (Atlanta). He is currently director of the PhD program for Medical & Molecular Imaging at University of Copenhagen. He obtained the MBA (executive) degree from Copenhagen Business School in 1997 and participated in "Leading the virtual company" program at Harvard Business School (Boston) from 2013-14. He also served as medical officer in the Royal Danish Navy (first lieutenant 1989, lieutenant commander 1994).
Andreas Kjær (born April 12, 1963) is a Danish physician-scientist and European Research Council (ERC) advanced grantee. He is professor at the University of Copenhagen and chief physician at Rigshospitalet, the National University Hospital of Denmark. He is board certified in Nuclear Medicine and his research is focused on molecular imaging with PET and PET/MRI and targeted radionuclide therapies (theranostics) in cancer. His achievements include development of several new PET tracers that have reached first-in-human clinical use. He has published more than 400 peer-review articles, filed 10 patents, supervised more than 40 PhD students and received numerous prestigious scientific awards over the years. He is a member of the Danish Academy of Technical Sciences
